I H Krakoff. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Alkaloids/therapeutic useAlkylating Agents/therapeutic useAntibiotics, Antineoplastic/therapeutic useAntimetabolites/therapeutic useAntineoplastic Agents/administration & dosageAntineoplastic Agents/adverse effectsAntineoplastic Agents/pharmacologyAntineoplastic Agents/therapeutic useBreast Neoplasms/drug therapyBurkitt Lymphoma/drug therapyDNA, Neoplasm/biosynthesisDrug SynergismFemaleHodgkin Disease/drug therapyHumansImmunosuppressive Agents/administration & dosageImmunosuppressive Agents/pharmacologyImmunosuppressive Agents/therapeutic useLeukemia/drug therapyLymphoma, Non-Hodgkin/drug therapyMaleMultiple Myeloma/drug therapyNeoplasms/drug therapyNeoplasms/metabolismNeuroblastoma/drug therapyOvarian Neoplasms/drug therapyPalliative CarePregnancyProstatic Neoplasms/drug therapyRNA, Neoplasm/biosynthesisSteroids/therapeutic useTesticular Neoplasms/drug therapyTrophoblastic Neoplasms/drug therapyWilms Tumor/drug therapy
Substances： See more » AlkaloidsAlkylating AgentsAntibiotics, AntineoplasticAntimetabolitesAntineoplastic AgentsDNA, NeoplasmImmunosuppressive AgentsRNA, NeoplasmSteroids
Year: 1971 PMID： 4102661 DOI： 10.1016/s0025-7125(16)32511-1
Source DB: PubMed Journal: Med Clin North Am ISSN： 0025-7125 Impact factor: 5.456